4//SEC Filing
Riddell Alastair 4
Accession 0001140361-22-000304
CIK 0001604191other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:07 PM ET
Size
5.2 KB
Accession
0001140361-22-000304
Insider Transaction Report
Form 4
Riddell Alastair
Director
Transactions
- Award
Stock option (right to buy)
2022-01-03+34,482→ 34,482 totalExercise: $1.45Exp: 2032-01-03→ Common stock, par value $0.0001 per share (34,482 underlying)
Footnotes (1)
- [F1]The stock option vests in equal quarterly installments on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
Documents
Issuer
First Wave BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001681349
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 9:07 PM ET
- Size
- 5.2 KB